Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Diagnostics
Special Issues
Skin Disease: Diagnosis and Management
share announcement

Skin Disease: Diagnosis and Management

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".

Deadline for manuscript submissions: 31 January 2025 | Viewed by 1002

Special Issue Editor

Dr. Jong Hee Lee

E-Mail Website
Guest Editor
Department of Dermatology, Samsung Medical Center, Seoul, Republic of Korea
Interests: scar; keloid; laser; severe atopic dermatitis; medical device

Special Issue Information

Dear Colleagues,

The Special Issue aims to provide a comprehensive platform for researchers, dermatologists and healthcare professionals to explore the latest advancements and research findings in the field of skin disease diagnosis and management. Skin diseases encompass a wide range of conditions that affect the skin, hair, nails and mucous membranes, presenting unique challenges in accurate diagnosis and effective treatment.

This Special Issue will focus on advancements in diagnostic tools, techniques and technologies for the precise identification and classification of various skin diseases. It will cover topics such as the application of dermatopathology, dermoscopy, molecular diagnostics and imaging modalities to improve the accuracy of diagnosis, including differentiating benign and malignant lesions. Additionally, it will explore the role of artificial intelligence (AI) and machine learning algorithms in aiding dermatologists in diagnosis and risk assessment. 

By compiling research articles, reviews and case studies, this Special Issue aims to provide valuable insights into the evolving landscape of skin disease diagnosis and management. It will facilitate the knowledge exchange, collaboration and development of novel diagnostic tools and treatment strategies to improve patient outcomes and the quality of life. The Special Issue is expected to contribute to the advancement of dermatology practice, fostering personalized and evidence-based approaches in the diagnosis and management of various skin diseases.

We look forward to your submission.

Dr. Jong Hee Lee
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • skin disease
  • dermatopathology
  • dermoscopy
  • molecular diagnostics
  • imaging

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Other

11 pages, 8150 KiB  
Case Report
A Case of Bullous Pemphigoid with Significant Infiltration of CD4-Positive T Cells during Treatment with Pembrolizumab, Accompanied by Pembrolizumab-Induced Multi-Organ Dysfunction
by Yoshihito Mima, Tsutomu Ohtsuka, Ippei Ebato, Yoshimasa Nakazato and Yuta Norimatsu
Diagnostics 2024, 14(17), 1958; https://doi.org/10.3390/diagnostics14171958 - 4 Sep 2024
Cited by 1 | Viewed by 648
Abstract
Immune checkpoint inhibitors (ICIs) activate T cells, causing immune-related adverse events (irAEs). Skin manifestations are common among irAEs, but ICI-associated bullous pemphigoid (BP) is rare. Inhibiting programmed death (PD)-1 signaling, in addition to causing epitope spreading, may disrupt B and T cell balance, [...] Read more.
Immune checkpoint inhibitors (ICIs) activate T cells, causing immune-related adverse events (irAEs). Skin manifestations are common among irAEs, but ICI-associated bullous pemphigoid (BP) is rare. Inhibiting programmed death (PD)-1 signaling, in addition to causing epitope spreading, may disrupt B and T cell balance, causing excessive autoantibody production against the skin’s basement membrane, leading to BP. A 70-year-old woman developed late-onset multi-organ irAEs, including diarrhea, thyroid dysfunction, and BP, while receiving pembrolizumab, a PD-1 inhibitor. This highlights the long-term risk of irAEs, which can occur 2–3 years after starting ICIs. In cases of multi-organ irAE, C-reactive protein levels and neutrophil/lymphocyte ratio are often low. These characteristics were observed in our case. Few papers address multiple organ involvement, highlighting the need to consider irAEs in a multi-organ context. While it is known that drug-induced skin reactions worsen as blood eosinophil counts increase, in our case, the eosinophil count remained normal, suggesting that ICI-associated BP might have been controlled without discontinuing the ICI and through tapering of low-dose oral prednisone treatment. Additionally, in this case, significant CD4-positive T cell infiltration was observed in the immunostaining examination of the blisters, indicating that severe CD4-positive T cell infiltration induced by the ICI might have led to multi-organ involvement, including severe diarrhea. Few reports focus on blood eosinophil counts in BP cases or discuss CD4 and CD8 immunostaining in BP cases. Therefore, future research should explore the relationship between blood eosinophil counts, immunostaining results, and the prognosis of irAEs, including BP, in treatment courses. Full article
(This article belongs to the Special Issue Skin Disease: Diagnosis and Management)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop